dfw tirzepatide Weight Loss Injections & Clinics Near You Tirzepatide | DirectMeds

FDA approves Lilly's Zepbound (tirzepatide) for chronic weight management owenhaskins Nov 8, 2023 4 min read Updated: Nov 9, 2023 The FDA has approved Eli Lilly and Company's Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors

This means food stays in your stomach longer, keeping you feeling full for a more extended period

The drug, manufactured by Danish firm Novo Nordisk, is delivered via a weekly injection and has been hailed a game changer in the battle against obesity

If symptoms persist, always consult your doctor

Prebiotics (fiber that feeds beneficial bacteria) might provide more reliable benefits than probiotics for GLP-1 support